Mobilization/transplantation of Ph1-negative blood progenitor cells in chronic myelogenous leukaemia

Annals of Oncology

Volumn 7, Issue SUPPL. 2, 1996, Pages 19-22

  Carella, A M ^a,b   Podesta M ^a   Lerma, E ^a   Dejana, A ^a   Prencipe, E ^a   Vassallo, F ^a   Crescenti, C ^a   Soracco, M ^a   Benvenuto, F ^a   Chimirri, F ^a   Carlier, P ^a   Florio, G ^a   Valbonesi, M ^a   Frassoni, F ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b NONE   (Italy)

Author keywords

Allogeneic transplantation; Autologous transplantation; Chemotherapy; Chronic myelogenous leukaemia; Graft versus host disease; Interferon alpha; Peripheral blood progenitor cells; Philadelphia negative cells; Review

Indexed keywords

ALLOTRANSPLANTATION; AUTOTRANSPLANTATION; CHRONIC MYELOID LEUKEMIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DRUG EFFECT; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHODOLOGY; MYELOID LEUKEMIA; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; REVIEW;

HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, MYELOID, PHILADELPHIA-NEGATIVE; RANDOMIZED CONTROLLED TRIALS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 2342617672     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/7.suppl_2.19     Document Type: Review

References (27)

1. bcr/abl gene of the Philadelphia chromosome. Science 1990; 247: 824-30.
2. Carlo-Stella C, Mangoni L, Piovani G et al. Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients. Blood 1994; 83: 1373-80.
3. Enright H, McGlave P. Chronic myelogenous leukemia. Curr Opin Hematol 1995; 2: 293-9.
4. Italian Cooperative Study Group on Chronic Myeloid Leukemia. Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 1994; 330: 820-5.
5. Allan NC, Richards SM, Shepherd PCA. UK Medical Research Council randomised, multicentre trial of interferon-α for chronic myeloid leukaemia: Improved survival irrespective of cytogenetic response. Lancet 1995; 345: 1392-7.
6. Helmann R, Helmpel H, Hasford J et al. Randomized comparison of interferon-α with busulfan and hydroxyurea in chronic myelogenous leukemia. Blood 1994; 134: 4064-77.
7. Enright H, Daniels K, Arthur D et al. Risk factors in marrow transplant for chronic myeloid leukemia: Overwhelming influence of early transplant. Blood 1993; 82: 647 (Abstr).
8. Davies SM, Ramsay NKC, Haake RJ et al. Comparison of engraftment in recipients of matched sibling or unrelated donor marrow allografts. Bone Marrow Transplant 1994; 13: 51-7.
9. Porter DL, Roth MS, McGarigle C et al. Induction of graft versus host disease as immunotherapy for relapsed chronic myeloid leukemia. N Engl J Med 1994; 330: 100-6.
10. Van Rhee F, Lin F, Cullis JO et al. Relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: The case for giving donor leukocyte transfusions before the onset of hematologic relapse. Blood 1994; 83: 3377-83.
11. Hoyle C, Gray R, Goldman J. Autografting for patients with CML in chronic phase: An update. Br J Haematol 1994; 86: 76-81.
12. Meloni G, Vignetti M, Cardillo AMF et al. Ablative chemotherapy followed by peripheral blood stem cells reinfusion for chronic myelogenous leukemia in chronic phase. Bone Marrow Transplant 1994; 14 (Suppl 3): 103 (Abstr).
13. Reiffers J, Goldman J, Meloni G et al. Autologous stem cell transplantation in chronic myelogenous leukemia: Retrospective analysis of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1994; 14: 407-10.
14. Simonsson B, Oberg G, Killander A et al. Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenic leukemia (CML). Bone Marrow Transplant 1994; 14 (Suppl 3): S55 (Abstr).
15. McGlave P, Miller J, Perry E et al. Autologous marrow transplant therapy for CML using marrow treated ex vivo with human recombinant interferon gamma. Blood 1994; 84 (Suppl 1): 537 (Abstr).
16. Vogler WR, Winton EF, James S et al. Autologous marrow transplantation after karyotypic conversion to normal in blastic phase of chronic myelocytic leukemia. Ann J Med 1983; 75: 1080-4.
17. Carlo-Stella C, Mangoni L, Almici C et al. Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide. Bone Marrow Transplant 1994; 14: 425-32.
18. Barnett MJ, Eaves CJ, Philips GL et al. Autografting with cultured marrow in chronic leukemia: Results of a pilot study. Blood 1994; 84: 724-32.
19. Goldman JM, Th'ng KH, Lowenthal RM. In vitro colony forming cells and colony stimulating factor in chronic granulocytic leukaemia. Br J Cancer 1974; 30: 1-12.
20. 1-positive chronic granulocytic leukemia. Blood 1980; 56: 1072-6.
21. Coulombel L, Kalousek DK, Eaves CJ et al. Long-term marrow culture reveals chromosomally normal haematopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myelogenous leukaemia. N Engl J Med 1983; 304: 1493-8.
22. 1-negative progenitors in treated as well as newly diagnosed patients. Blood 1984; 63: 1172-7.
23. Korbling M, Burke P, Braine H et al. Successful engraftment of blood-derived normal hemopoietic stem cells in chronic myelogenous leukemia. Exp Hematol 1981; 9: 684-7.
24. Carella AM, Podestà M, Frassoni F et al. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant 1993; 12: 267-71.
25. Carella AM, Frassoni F, Pollicardo N et al. Philadelphia chromosome-negative peripheral blood stem cells can be mobilized in the early phase of recovery after a myelosuppressive chemotherapy in Philadelphia chromosome-positive acute lymphoblastic leukaemia. Br J Haematol 1995; 89: 535-8.
26. Bergamaschi G, Podestà M, Frassoni F et al. Restoration of normal polyclonal hemopoiesis in patients with chronic myeloid leukemia autografted with Ph-negative peripheral stem cells. Br J Haematol 1994; 87: 867-70.
27. Podestà M, Piaggio G, Frassoni F et al. Very primitive hemopoietic cells (LTC-IC) are present in Philadelphia negative cytaphereses collected during early recovery after chemotherapy for chronic myelogenous leukemia. Bone Marrow Transplant 1995; 16: 549-55.